Tag: Pharmaceutical deal
Roivant Sells Dermatology Spinoff to Organon in $1.2B Deal
Roivant Sciences, a prominent player in the biotech industry, has once again demonstrated its prowess in dealmaking by announcing the sale of one of...
BREAKING NEWS
Bluebird Bio Sold to Carlyle, SK Capital for Under $30M
Bluebird Bio, a once-promising biotech company, made headlines recently with its decision to sell itself and its portfolio of gene therapies to investment firms...
